TOTAROL
DEAD

Serial Number

79353561

Owner

Specialist Ingredients Limited

Filing Date

Jul 1, 2022

Add to watchlist:

No watchlists yet
View on USPTO

TOTAROL Trademark

Serial Number: 79353561

TOTAROL is a trademark filed by Specialist Ingredients Limited on July 1, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Specialist Ingredients Limited (7 trademarks)

Level 1,

Entity Type: 98

Hyperganic Biogroup Limited

c/- Johnston Associates Chartered Accountants Limi

Entity Type: 98

MENDE BIOTECH LIMITED (7 trademarks)

RD 11 Masterton 5871

Entity Type: 99

Trademark Details

Filing Date

July 1, 2022

Registration Date

Not Registered

Goods & Services

Anti-bacterial preparations, namely, wood extracts for human and veterinary use

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 26, 2026 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Jan 1, 2026 NREP
CHANGE OF OWNER RECEIVED FROM IB
Nov 6, 2025 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 14, 2024 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Nov 28, 2024 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 28, 2024 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 15, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 27, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 27, 2024 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 27, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 27, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 27, 2023 ABN2
REFUSAL PROCESSED BY IB
May 24, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 2, 2023 RFCS
REFUSAL PROCESSED BY MPU
May 2, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 11, 2023 RFCR
NON-FINAL ACTION WRITTEN
Mar 10, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 3, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 1, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 28, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 27, 2022 REPR